article thumbnail

Potential and Challenges of the APAC Pharmaceutical Industry

Viseven

from 2022 to 2027. Specifically, she engaged with several important stakeholders and received valuable information about future sales and marketing strategies, decision-making vision, and innovation trends among Chinese pharmaceutical companies. This role is significant because the pharma market in APAC is increasing.

article thumbnail

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

As a result, some pharmaceutical companies are turning to third parties. GlobalData forecasts Biologics to significantly overtake sales of small molecules by $120 billion by 2027. Moreover, skilled manpower is required to run these facilities. Please check your email to download the Whitepaper.

article thumbnail

Pliant snags $287.5 million in oversubscribed public offering amid market uncertainty

Pharmaceutical Technology

A Pliant spokesperson said, “This successful transaction, along with existing cash, cash equivalents, loan agreement and short-term investments, provides for operations to be funded to mid-2027, a year past the expected IPF Phase 2b clinical trial readout.” The company said a Phase IIb trial initiation should be expected in mid-2023.

FDA 59